Received Mar 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
flu like; This non-serious case was reported by a consumer via sales rep and described the occurrence of influenza like illness in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced influenza like illness (Verbatim: flu like). The outcome of the influenza like illness was resolved (duration 2 days). It was unknown if the reporter considered the influenza like illness to be related to Shingrix. It was unknown if the company considered the influenza like illness to be related to Shingrix. Additional Information: GSK Receipt Date: 18-MAR-2026 The patient reported significant flu like side effects for 2 days after taking a dose of Shingrix. It was unknown if it was the first or second does in the series. The batch number was not provided and unable to contact the reporter.